fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search

Search Results for:"Cancer Treatment for Children"
Sheba and Vidac

Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness

While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few months and hinder the therapy’s effectiveness, Sheba completes the entire treatment process in less than two weeks thanks to its specialized in-house laboratory. However, not all patients respond to the […]
Aml remission possible with Zantrene as part of medication regimen.

Zantrene May Promote Long-term Remission in  Acute Myeloid Leukemia Patients, Sheba Study Indicates

Zantrene, also known by its generic name bisantrene dihydrochloride, is an anti-cancer drug used both as a low-dose targeted precision oncology agent as well as a cardio-protective chemotherapy drug. Zantrene was developed by Australian Race Oncology, who, together with Sheba, launched a clinical trial for the treatment of relapsed or refractory acute myeloid leukemia (AML) […]
REACT

West Bank and Gaza Medical Professionals Attend a Milestone Sheba Oncology Conference

As part of the REACT 2023 regional conference, which took place on Monday, March 20th, Sheba’s premier physicians showcased the latest in oncologic care, focusing on pediatrics, marking a significant breakthrough for Israeli-Palestinian medical cooperation. A leader in clinical care, research, and innovation, Sheba is committed to not only offering world-class care to all patients, […]
Non-Hodgkin's Lymphoma story of Marina's journey from diagnosis to treatment.

Overcoming Non-Hodgkin’s Lymphoma: Maria’s Story

Maria’s story started a year before her diagnosis. She began feeling tired and apathetic, but blood tests indicated nothing was wrong. When symptoms worsened, her doctor suggested taking blood tests every week to monitor changes over time. After undergoing a few tests, she was referred to an ultrasound, which revealed that she was suffering from […]
Neuroblastoma in Kids: Igor’s Story

Fighting for a Future: Igor’s Story of Hope and Determination

Igor’s mother recalls the birth of her son as a challenging experience. He was hospitalized for about a month following respiratory failure requiring resuscitation. Fortunately, Igor grew up normally. “He is a wonderful boy, loves to play with animals and cars, and is very energetic,” describes his mother, Alina.  However, upon graduating 1st grade in […]
T-cell Therapy for Multiple Myeloma is available at Sheba Medical Center in Israel

CAR T-cell Therapy for Multiple Myeloma at Sheba

CAR T-cell therapy is a revolutionary blood cancer treatment that helps the body combat tumors using its own T-cells. The therapy involves collecting the patient’s blood, separating T-cells, and genetically engineering them to produce chimeric antigen receptors (CARs). These allow the T-cells to recognize tumor cells, targeting and destroying them. After their alteration, T-cells are […]
Ibrahim’s Battle With Non-Hodgkin's Lymphoma with car-t therapy

From Dire Plight to Miraculous Recovery: Ibrahim’s Battle With Non-Hodgkin’s Lymphoma

When West Bank doctors were unable to help, Ibrahim was referred to Sheba Medical Center by a friend. It was there he discovered compassion that surpassed his expectations as well as groundbreaking medicine.
fight with non-hodgkin's lymphoma

N.P’s fight with non-Hodgkin’s lymphoma

Before it all began, I was working as a data storage firmware engineer in my native India. I loved my career, and also enjoyed frequent hikes with friends on weekends.My life was turned upside down when enlarged tonsils and swollen lymph nodes in my neck turned out to be more than just a bad throat […]
Immunotherapy combination can prolong patient lifepsan

A New Study: Combined Immunotherapy Can Prolong Patient Lifespan

According to a new Sheba study, a combined immunotherapy regimen is more effective against metastatic melanoma.